Clinical Use, Interpretation, and Limitations of Sudoscan in Diabetes Care

Abstract

Background

Diabetic peripheral neuropathy (DPN) and diabetic autonomic neuropathy (DAN) are prevalent yet underdiagnosed complications. While not a replacement for traditional diagnostics, Sudoscan is a noninvasive, rapid diagnostic device that evaluates sudomotor function through electrochemical skin conductance (ESC), offering a promising tool for screening neuropathic complications in routine clinical settings.

Objectives

This practice point article is a narrative review of the indications, clinical utility, interpretation, and limitations of Sudoscan within diabetes clinics.

Key Practical Points

Evidence suggests that Sudoscan demonstrates high sensitivity (up to 87.5%) and moderate specificity for detecting DPN and DAN. It provides objective, quick assessments, and its operation does not require specialized training, enhancing feasibility in primary care and specialty clinics. The ESC and cardiovascular autonomic neuropathy risk scores derived from Sudoscan correlate with established tests, such as nerve conduction studies and cardiovascular reflex tests. Furthermore, Sudoscan supports early detection, risk stratification, and monitoring of disease progression. Despite its advantages, Sudoscan's diagnostic accuracy can be influenced by factors such as age and ethnicity, and ESC thresholds remain an area requiring standardization. It is most effective when used as part of a broader diagnostic strategy.

Conclusion

This article provides clinicians with practical guidance on integrating Sudoscan into diabetes care, thereby enhancing the early identification and management of neuropathic complications.

Keywords

diabetic neuropathy - sudoscan - autonomic dysfunction - diabetes screening - electrochemical skin conductance - small fiber neuropathy

Author's Contribution

The author who proposed the study, performed the literature searches, and drafted the manuscript.

Compliance with Ethical Principles

No ethical approval is required for a review-type study.

Publikationsverlauf

Artikel online veröffentlicht:
08. September 2025

• References

• 1 Savelieff MG, Elafros MA, Viswanathan V, Jensen TS, Bennett DL, Feldman EL. The global and regional burden of diabetic peripheral neuropathy. Nat Rev Neurol 2025; 21 (01) 17-31
• 2 American Diabetes Association Professional Practice Committee. 12. Retinopathy, neuropathy, and foot care: standards of care in diabetes-2025. Diabetes Care 2025; 48 (1, suppl 1): S252-S265
• 3 Malik RA. GAED Medal Lecture 2022: challenging the dogma in diabetic neuropathy and beyond. J Diab Endocrine Pract 2023; 6: 3-10
• 4 Gavan DE, Gavan A, Bondor CI. et al. SUDOSCAN, an innovative, simple and non-invasive medical device for assessing sudomotor function. Sensors (Basel) 2022; 22 (19) 7571
• 5 Selvarajah D, Cash T, Davies J. et al. SUDOSCAN: a simple, rapid, and objective method with potential for screening for diabetic peripheral neuropathy. PLoS One 2015; 10 (10) e0138224
• 6 Krieger SM, Reimann M, Haase R, Henkel E, Hanefeld M, Ziemssen T. Sudomotor testing of diabetes polyneuropathy. Front Neurol 2018; 9: 803
• 7 Casellini CM, Parson HK, Richardson MS, Nevoret ML, Vinik AI. Sudoscan, a noninvasive tool for detecting diabetic small fiber neuropathy and autonomic dysfunction. Diabetes Technol Ther 2013; 15 (11) 948-953
• 8 Yajnik CS, Kantikar V, Pande A. et al. Screening of cardiovascular autonomic neuropathy in patients with diabetes using non-invasive quick and simple assessment of sudomotor function. Diabetes Metab 2013; 39 (02) 126-131
• 9 Yuan T, Li J, Fu Y. et al. A cardiac risk score based on sudomotor function to evaluate cardiovascular autonomic neuropathy in asymptomatic Chinese patients with diabetes mellitus. PLoS One 2018; 13 (10) e0204804
• 10 Lefaucheur JP. The value of electrochemical skin conductance measurement by Sudoscan^® for assessing autonomic dysfunction in peripheral neuropathies beyond diabetes. Neurophysiol Clin 2023; 53 (02) 102859
• 11 Vinik AI, Nevoret ML, Casellini C. The new age of sudomotor function testing: a sensitive and specific biomarker for diagnosis, estimation of severity, monitoring progression, and regression in response to intervention. Front Endocrinol (Lausanne) 2015; 6: 94
• 12 Jin J, Wang W, Gu T. et al. The application of SUDOSCAN for screening diabetic peripheral neuropathy in Chinese population. Exp Clin Endocrinol Diabetes 2018; 126 (08) 472-477
• 13 Riveline JP, Mallone R, Tiercelin C. et al. Validation of the Body Scan^®, a new device to detect small fiber neuropathy by assessment of the sudomotor function: agreement with the Sudoscan^® . Front Neurol 2023; 14: 1256984
• 14 Vinik AI, Smith AG, Singleton JR. et al. Normative values for electrochemical skin conductances and impact of ethnicity on quantitative assessment of sudomotor function. Diabetes Technol Ther 2016; 18 (06) 391-398
• 15 Freedman BI, Bowden DW, Smith SC, Xu J, Divers J. Relationships between electrochemical skin conductance and kidney disease in Type 2 diabetes. J Diabetes Complications 2014; 28 (01) 56-60
• 16 Lin K, Wu Y, Liu S, Huang J, Chen G, Zeng Q. The application of Sudoscan for screening microvascular complications in patients with type 2 diabetes. PeerJ 2022; 10: e13089
• 17 Huang CC, Lai YR, Cheng BC. et al. Sudoscan as substitute for quantitative sudomotor axon reflex test in composite autonomic scoring scale and its correlation with composite autonomic symptom scale 31 in type 2 diabetes. Neurophysiol Clin 2023; 53 (06) 102915
• 18 Akbar M, Wandy A, Soraya GV, Goysal Y, Lotisna M, Basri MI. Sudomotor dysfunction in diabetic peripheral neuropathy (DPN) and its testing modalities: a literature review. Heliyon 2023; 9 (07) e18184
• 19 Goel A, Shivaprasad C, Kolly A, Vijaya Sarathi HA, Atluri S. Comparison of electrochemical skin conductance and vibration perception threshold measurement in the detection of early diabetic neuropathy. PLoS One 2017; 12 (09) e0183973
• 20 Duchesne M, Richard L, Vallat JM, Magy L. Assessing sudomotor impairment in patients with peripheral neuropathy: comparison between electrochemical skin conductance and skin biopsy. Clin Neurophysiol 2018; 129 (07) 1341-1348
• 21 O'Bryan R, Kincaid J. Nerve conduction studies: basic concepts and patterns of abnormalities. Neurol Clin 2021; 39 (04) 897-917
• 22 Kane NM, Oware A. Nerve conduction and electromyography studies. J Neurol 2012; 259 (07) 1502-1508
• 23 Oaklander AL, Nolano M. Scientific advances in and clinical approaches to small-fiber polyneuropathy: a review. JAMA Neurol 2019; 76 (10) 1240-1251
• 24 Galosi E, Litewczuk D, De StefanoG. et al. Diagnostic accuracy of quantitative sensory testing for detecting small fiber impairment in polyneuropathy and diagnosing small fiber neuropathy. Pain. 2025 Jun 19. (e-pub ahead of print)
• 25 Backonja MM, Attal N, Baron R. et al. Value of quantitative sensory testing in neurological and pain disorders: NeuPSIG consensus. Pain 2013; Sep; 154 (09) 1807-1819
• 26 Shy ME, Frohman EM, So YT. et al; Therapeutics and technology assessment subcommittee of the American Academy of Neurology. Quantitative sensory testing: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2003; Mar 25 60 (06) 898-904
• 27 Gylfadottir SS, Itani M, Kristensen AG. et al. Assessing corneal confocal microscopy and other small fiber measures in diabetic polyneuropathy. Neurology 2023; 100 (16) e1680-e1690
• 28 Bjørnkaer A, Gaist LM, Holbech JV. et al. Corneal confocal microscopy in small and mixed fiber neuropathy-comparison with skin biopsy and cold detection in a large prospective cohort. J Peripher Nerv Syst 2023; 28 (04) 664-676
• 29 Chen X, Graham J, Dabbah MA. et al. Small nerve fiber quantification in the diagnosis of diabetic sensorimotor polyneuropathy: comparing corneal confocal microscopy with intraepidermal nerve fiber density. Diabetes Care 2015; 38 (06) 1138-1144
• 30 Alam U, Jeziorska M, Petropoulos IN. et al. Diagnostic utility of corneal confocal microscopy and intra-epidermal nerve fibre density in diabetic neuropathy. PLoS One 2017; 12 (07) e0180175
• 31 Dhage S, Ferdousi M, Adam S. et al. Corneal confocal microscopy identifies small fibre damage and progression of diabetic neuropathy. Sci Rep 2021; 11 (01) 1859
• 32 Tavakoli M, Petropoulos IN, Malik RA. Corneal confocal microscopy to assess diabetic neuropathy: an eye on the foot. J Diabetes Sci Technol 2013; 7 (05) 1179-1189
• 33 Gad H, Petropoulos IN, Khan A. et al. Corneal confocal microscopy for the diagnosis of diabetic peripheral neuropathy: a systematic review and meta-analysis. J Diabetes Investig 2022; 13 (01) 134-147
• 34 Azmi S, Ferdousi M, Kalteniece A. et al. Corneal confocal microscopy identifies early and definite diabetic cardiac autonomic neuropathy. Diabetes Res Clin Pract 2025; 224: 112172
• 35 Ponirakis G, Al-Janahi I, Elgassim E. et al. Glucose-lowering medication associated with weight loss may limit the progression of diabetic neuropathy in type 2 diabetes. J Peripher Nerv Syst 2024; 29 (04) 406-414